Showing 981 - 1,000 results of 104,723 for search '(( 3 points decrease ) OR ( 5 ((((step decrease) OR (nn decrease))) OR (a decrease)) ))', query time: 1.75s Refine Results
  1. 981
  2. 982
  3. 983
  4. 984
  5. 985
  6. 986
  7. 987

    ATP assay. by Dong Ma (584680)

    Published 2020
    Subjects:
  8. 988
  9. 989
  10. 990
  11. 991
  12. 992
  13. 993

    Decreased Sho levels in ScN2a-Sho cells. by Joel C. Watts (195735)

    Published 2011
    “…(<b>C</b>) Quantification of Sho levels in ScN2a-Sho-1 (<i>n</i> = 10) and ScN2a-Sho-2 (<i>n</i> = 5) subclones revealed a significant decrease of 40–45% compared to the uninfected parental cell line (<i>n</i> = 15) (***<i>P</i><0.001).…”
  14. 994
  15. 995
  16. 996

    FUD transiently decreased IOP in mice injected with Ad5-TGFβ2 viral vector. by Jennifer A. Faralli (4907311)

    Published 2020
    “…(B) IOPs were monitored for 5 more days (until Day 22) in a subset of mice from A. …”
  17. 997
  18. 998

    Identification of small molecules that inhibit viral M mRNA nuclear export and/or decrease viral M mRNA levels. by Matthew Esparza (8661219)

    Published 2020
    “…To better visualize the distribution of compounds within the desired range (Z-score < -3), the Z-score range of the graph has been focused to view data points that show decrease in viral M mRNA fluorescence.…”
  19. 999

    Data extraction grid. by Heloisa Ricci Conesa (18291210)

    Published 2024
    “…No homogenous trends were identified in incidence rates across countries, or in detection of S. pneumoniae as a cause of AOM over time. There were indications of a reduction in hospitalization rates (decreases between 24.5–38.8% points, depending on country, PCV type and time since PCV introduction) and antibiotic resistance (decreases between 14–24%, depending on country), following the widespread use of PCVs over time. …”
  20. 1000

    Incidence rates of AOM cases. by Heloisa Ricci Conesa (18291210)

    Published 2024
    “…No homogenous trends were identified in incidence rates across countries, or in detection of S. pneumoniae as a cause of AOM over time. There were indications of a reduction in hospitalization rates (decreases between 24.5–38.8% points, depending on country, PCV type and time since PCV introduction) and antibiotic resistance (decreases between 14–24%, depending on country), following the widespread use of PCVs over time. …”